HOME >> MEDICINE >> NEWS
Trial reveals safer and simpler approach to treating children with cystic fibrosis

Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week's issue of THE LANCET.

Aminoglycoside antibiotics are widely used for the management of patients who have cystic fibrosis and chronic chest infection with a bacterium called Pseudomonas aerginosa. Currently patients are given aminoglycosides three times daily. The drugs can cause damage to kidney function and hearing loss.

Alan Smyth (University of Nottingham, UK) and colleagues recruited 219 cystic fibrosis patients (125 children and 94 adults) between 1999 and 2003 in the UK. The patients were randomly assigned to receive an aminoglycoside called tobramycin intravenously once or three times daily for 14 days. The researchers measured changes in lung function and found that the two treatments had a similar effect. However in children, the once daily treatment caused fewer kidney related side effects.

Dr Alan Smyth comments: "Our results are likely to affect aminoglycoside prescription in cystic fibrosis in clinical practice. Once daily treatment may be preferred by patients receiving intravenous antibiotics because of its convenience. Antipseudomonal antibiotics are usually given as combinations of two or more drugs in cystic fibrosis because of concerns of emerging antibiotic resistance. Most other antipseudomonal antibiotics need to be given three times daily and so further development of other once daily antibiotics would be useful."

In an accompanying commentary Heather VandenBussche (Bronson Methodist Hospital, Michigan, USA) and Michael Klepser (Ferris State University College of Pharmacy, Michigan, USA) write that several unanswered questions persist about once daily aminoglycoside dosing in cystic fibrosis patients.

Dr VandenBussche concludes: " Smyth and colleagues' report provides some useful insights into
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
10-Feb-2005


Page: 1 2

Related medicine news :

1. Trials launched to test treatment of cognitive dysfunction in schizophrenia
2. Randomisation phase of the DIRECT programme (DIabetic REtinopathy Candesartan Trials) completed
3. Trials on hormone therapy and hypertension treatment change practice, medication usage of patients
4. Trial results have dramatically reduced HRT use
5. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
6. Trial opens new possibilities for improving survival with a novel heart attack drug
7. Clinical Trials Litigation: Legal & Ethical Issues in Human Subjects Research
8. National Lung Screening Trial
9. New awards, expanded focus for Pediatric AIDS Clinical Trials Group
10. AAPS Workshop to Examine Chemistry and Manufacturing Controls Trials, Emerging Products
11. Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... Dr. ... psychology and brain biology of why some people could care less, demonstrating a “whatever” ... While there are many reasons for this, one often overlooked reason relates to being ...
(Date:8/2/2018)... ... August 02, 2018 , ... ... recruit caregivers to participate in brain cancer caregiver and patient clinical trials at ... Health Services of Southern California. , At the Pacific Neuroscience Institute ...
(Date:8/2/2018)... (PRWEB) , ... August 02, ... ... national medical claims management solutions provider, announced today that it has acquired ... evaluations (IMEs), medical record reviews, peer reviews, and related services. , Medlogix ...
(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... Josh Sprague, ... hydration products for high-intensity athletes, recently sat down with SGB Media to discuss his ... a simple philosophy. His goal was to create better, more efficient gear to help ...
(Date:8/1/2018)... ... August 01, 2018 , ... Matt ... and Vice President, Addiction Treatment Services, Behavioral Health Division of Universal ... Services business of Universal Health Services, which includes the FRN portfolio comprised of ...
Breaking Medicine News(10 mins):
(Date:8/2/2018)... ... ... What: The Wharton School is pleased to invite business journalists to apply ... who cover aspects of public policy to attend the Wharton Seminars for Business ... cost of tuition, course materials, most group meals, lodging for three nights and airfare ...
(Date:8/2/2018)... ... August 02, 2018 , ... Periodontist, Dr. Andres Sanchez, welcomes ... lengthening treatment at his Eden Prairie, MN practice. Aesthetic crown lengthening or ... decades of experience, Dr. Sanchez is excited to welcome new patients for a ...
(Date:8/2/2018)... ... August 02, 2018 , ... Clay and Associates DDS, PLC is excited ... Wallingford will join Dr. John Clay and Dr. Shaun O’Neill as an associate dentist ... for all of their patients' dental hygiene, encapsulates the core values of the professional ...
Breaking Medicine Technology:
Cached News: